SUCRALFATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for sucralfate and what is the scope of patent protection?

Sucralfate is the generic ingredient in two branded drugs marketed by Abbvie, Abon Pharms Llc, Amneal, Hikma, Mylan, Pd Partners, Strides Pharma, Vistapharm Llc, Amneal Pharms, Nostrum Labs Inc, Teva, and Zydus Lifesciences, and is included in thirteen NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for sucralfate. Forty-one suppliers are listed for this compound.

Sponsor	Phase
National Cheng-Kung University Hospital	N/A
National Cheng-Kung University Hospital	Phase 1
Memorial Sloan Kettering Cancer Center	Phase 2

Sponsor

Phase

National Cheng-Kung University Hospital

N/A

National Cheng-Kung University Hospital

Phase 1

Memorial Sloan Kettering Cancer Center

Phase 2

US Patents and Regulatory Information for SUCRALFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Lifesciences	SUCRALFATE	sucralfate	TABLET;ORAL	215705-001	May 3, 2023	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Strides Pharma	SUCRALFATE	sucralfate	SUSPENSION;ORAL	216474-001	May 21, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	CARAFATE	sucralfate	SUSPENSION;ORAL	019183-001	Dec 16, 1993	AB	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Nostrum Labs Inc	SUCRALFATE	sucralfate	TABLET;ORAL	074415-001	Jun 8, 1998	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva	SUCRALFATE	sucralfate	TABLET;ORAL	070848-001	Mar 29, 1996	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan	SUCRALFATE	sucralfate	SUSPENSION;ORAL	212913-001	Sep 12, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	SUCRALFATE	sucralfate	SUSPENSION;ORAL	212769-001	Jul 23, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	CARAFATE	sucralfate	TABLET;ORAL	018333-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

TABLET;ORAL

Approved Prior to Jan 1, 1982

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	13
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	41
Clinical Trials:	25
Drug Prices:	Drug price trends for SUCRALFATE
Drug Sales Revenues:	Drug sales revenues for SUCRALFATE
What excipients (inactive ingredients) are in SUCRALFATE?	SUCRALFATE excipients list
DailyMed Link:	SUCRALFATE at DailyMed

SUCRALFATE - Generic Drug Details

What are the generic sources for sucralfate and what is the scope of patent protection?

Summary for SUCRALFATE

Recent Clinical Trials for SUCRALFATE

Pharmacology for SUCRALFATE

Medical Subject Heading (MeSH) Categories for SUCRALFATE

Anatomical Therapeutic Chemical (ATC) Classes for SUCRALFATE

US Patents and Regulatory Information for SUCRALFATE

Expired US Patents for SUCRALFATE

Make Better Decisions: Try a trial or see plans & pricing